Viewing nowMicater 80 mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201206742 · Approved 2012.09.11 · Insurance code 642904560
Treatment of essential hypertension; reduction of cardiovascular disease risk
This medication is used for the treatment of essential hypertension. Additionally, it is administered to high-risk diabetic patients aged 55 and older who are intolerant to ACE inhibitors, with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack, or evidence of end-organ damage, to help reduce the risk of myocardial infarction, stroke, and death from cardiovascular disease. In other words, this medication is effectively used for blood pressure control and reduction of cardiovascular risk.
1. Essential hypertension Adults: Administer 40 mg of telmisartan orally once daily with water; it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This medication has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended to administer 80 mg of this medication orally once daily with water; it may be taken with or without food. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so treatment should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals with allergies to this medication or its ingredients, in pregnant or breastfeeding women, individuals with severe liver disease, patients with a history of certain vascular swelling conditions, and patients with diabetes or severe kidney impairment. Elderly individuals, patients with hyperkalemia, liver disease, certain heart conditions, gastrointestinal disorders, and renal artery hypertension should use this medication with caution. During treatment, various side effects may occur, including headache, dizziness, cough, dyspepsia, skin rash, muscle pain, and renal function abnormalities. If any unusual symptoms occur, immediate consultation with healthcare professionals is required. Particularly, if sudden low blood pressure, severe allergic reactions, angioedema, hyperkalemia, or renal function deterioration occurs, treatment should be stopped immediately and appropriate medical care should be obtained. It is important to administer this medication while regularly monitoring renal function and blood potassium levels, as hypotension may occur in conditions of reduced blood volume or sodium depletion. This medication may interact with other medications that enhance or inhibit blood pressure-lowering effects, so it is essential to inform healthcare professionals of any other medications being taken. Usage should be avoided during pregnancy or breastfeeding, and particularly after the second trimester, monitoring fetal renal function and skull development is recommended. Safety and efficacy have not been established for children under 18 years of age, so use in this population is discouraged. Elderly patients are at risk of stroke and other complications due to excessive blood pressure lowering, so patient status must be closely monitored during treatment. In the event of an overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so immediate medical treatment is essential. This medication is not removed by dialysis, therefore, caution is required. Keep this medication out of the reach of children, do not change the original packaging, and it is advisable to open the packaging just before use. During treatment, caution is warranted while driving or operating hazardous machinery, as dizziness or fainting may occur.
Upper respiratory tract infection, pharyngitis, sinusitis, urinary tract infection, cystitis, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, hyponatremia, depression, insomnia, anxiety, syncope, drowsiness, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, cough, interstitial lung disease, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, taste disturbances, liver function abnormalities, liver dysfunction, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin eruption, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute kidney failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated liver enzymes, increased serum creatine kinase, decreased hemoglobin, facial spasms, sensory disturbances, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, weakness, edema, decreased libido, facial edema, alopecia, conjunctivitis, tinnitus, petechiae, headache, dizziness, palpitations, nausea, inadequate effect, arrhythmia, shock, loss of consciousness, jaundice, symptoms resembling anaphylaxis, interstitial pneumonia, rhabdomyolysis, blood pressure reduction, abnormal blood pressure control, syncope due to blood pressure reduction, loss of consciousness due to blood pressure reduction, abnormal serum potassium levels, increased serum creatinine, elevated blood urea nitrogen, increased plasma renin activity, hypertrophy and proliferation of periglomerular cells
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is advisable to maintain the storage temperature between 1°C and 30°C. This will help to preserve the medication's effectiveness and safety over time.
White or off-white, oval-shaped tablets that are convex on both sides
30 tablets/box[((10 tablets/Alu-Alu)x3)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.